We are live on ! Find out more
TS

Thomas Steyer Farallon Capital Management

AUM $21.7B
1-Year Est. Return 79.24%
 

Thomas Steyer founded Farallon Capital Management, a pioneering multi-strategy firm spanning credit, equities, real estate, and event-driven investing. Farallon became known for rigorous research and opportunistic capital allocation across cycles. Although Steyer later focused on public advocacy, the Farallon name remains important in hedge fund history and ongoing 13F tracking.

This Fund
S&P 500
This Quarter Est. Return
+1.5%
1 Year Est. Return
+79.24%
3 Year Est. Return
+204.51%
5 Year Est. Return
+270.91%
10 Year Est. Return
+1,884.18%
AUM
$21.4B
AUM Growth
-$3.07B
Cap. Flow
-$3.45B
Cap. Flow %
-16.12%
Top 10 Hldgs %
34%
Holding
335
New
40
Increased
37
Reduced
44
Closed
34

Top Buys

Rank Stock Value
1
ARMK icon
Aramark
ARMK
+$209M
2
KSU
Kansas City Southern
KSU
+$193M
3
HWM icon
Howmet Aerospace
HWM
+$184M
4
MIC
Macquarie Infrastructure Holdings, LLC
MIC
+$172M
5
TMUS icon
T-Mobile US
TMUS
+$160M

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$1.42B
2
MXIM
Maxim Integrated Products
MXIM
+$476M
3
WTW icon
Willis Towers Watson
WTW
+$468M
4
WORK
Slack Technologies, Inc.
WORK
+$462M
5
AON icon
Aon
AON
+$371M

Sector Composition

Rank Sector Weight
1 Healthcare 28.83%
2 Technology 13.3%
3 Industrials 11.55%
4 Communication Services 11.47%
5 Financials 11.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BX icon
26
Blackstone
BX
$108B
$309M 1.44%
2,659,536
-262,200
-9% -$30.4M
NOW icon
27
ServiceNow
NOW
$133B
$309M 1.44%
2,481,500
-128,500
-5% -$15.6M
CNC icon
28
Centene
CNC
$32.1B
$285M 1.33%
4,572,875
-177,125
-4% -$11.8M
CHTR icon
29
Charter Communications
CHTR
$17.9B
$277M 1.29%
381,001
-44,900
-11% -$34.1M
V icon
30
Visa
V
$693B
$277M 1.29%
1,243,504
-5,900
-0.5% -$1.38M
HLT icon
31
Hilton Worldwide
HLT
$73.5B
$275M 1.29%
2,085,077
-215,000
-9% -$27.2M
SHW icon
32
Sherwin-Williams
SHW
$84.1B
$271M 1.27%
969,868
-75,300
-7% -$22M
FIS icon
33
Fidelity National Information Services
FIS
$21.3B
$267M 1.25%
2,192,172
-908,186
-29% -$122M
TRU icon
34
TransUnion
TRU
$16.2B
$228M 1.07%
2,031,982
-750,800
-27% -$88.3M
EFX icon
35
Equifax
EFX
$22.6B
$226M 1.05%
891,583
+388,199
+77% +$101M
EXEL icon
36
Exelixis
EXEL
$13.4B
$204M 0.95%
9,659,712
-1,340,288
-12% -$24.9M
SJR
37
DELISTED
Shaw Communications Inc.
SJR
$182M 0.85%
6,270,000
+1,225,000
+24% +$35.5M
MIC
38
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
$177M 0.83%
+4,361,050
New +$172M
AMRS
39
DELISTED
Amyris Inc.
AMRS
$161M 0.75%
11,718,925
-1,391,075
-11% -$19.9M
ALNY icon
40
Alnylam Pharmaceuticals
ALNY
$31.6B
$154M 0.72%
814,301
-135,699
-14% -$25.5M
BEAM icon
41
Beam Therapeutics
BEAM
$3.07B
$149M 0.7%
1,717,590
+217,590
+15% +$21.9M
NTRA icon
42
Natera
NTRA
$47.9B
$145M 0.68%
1,300,134
+800,134
+160% +$91.7M
FATE icon
43
Fate Therapeutics
FATE
$279M
$137M 0.64%
2,311,398
+406,398
+21% +$31.9M
AVTR icon
44
Avantor
AVTR
$9.78B
$134M 0.62%
3,265,151
+1,960,151
+150% +$76.6M
IOVA icon
45
Iovance Biotherapeutics
IOVA
$3.76B
$132M 0.61%
5,339,994
+89,994
+2% +$2.12M
HZNP
46
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$128M 0.6%
1,172,174
+672,174
+134% +$69.8M
CTLT
47
DELISTED
CATALENT, INC.
CTLT
$124M 0.58%
+930,199
New +$116M
ENTA icon
48
Enanta Pharmaceuticals
ENTA
$392M
$113M 0.53%
1,995,000
– –
COHR
49
DELISTED
Coherent Inc
COHR
$105M 0.49%
420,000
– –
LU icon
50
Lufax Holding
LU
$1.2B
$100M 0.47%
3,589,225
+758,125
+27% +$25.2M
1
2
3 4 5

Similar funds

BG
Bahl & Gaynor Cincinnati, Ohio $21.7B AUM 30.58% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $21.7B AUM 41.93% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $21.5B AUM 23.65% 1-Year Est. Return
CHP
Castle Hook Partners New York $21.8B AUM 215.45% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Thomas Steyer's Q3 2021 Portfolio in Review

As of Q3 2021, Thomas Steyer held 335 positions worth $21.4B, down 13% from $24.5B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Thomas Steyer withdrew a net $3.45B in Q3 2021, closing 34 positions and reducing 44 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $1.42B position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 30% a quarter earlier, followed by Technology and Industrials.

Against the trend, Thomas Steyer opened a new position in Macquarie Infrastructure Holdings, LLC worth $177M.

  • Thomas Steyer's largest Q3 2021 buy was Macquarie Infrastructure Holdings, LLC: 4,361,050 shares worth $177M.
  • Thomas Steyer added most to Aramark in Q3 2021, an estimated $209M increase.
  • Thomas Steyer's biggest Q3 2021 reduction was Willis Towers Watson, cutting an estimated $468M.
  • Thomas Steyer fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $1.42B.
  • Thomas Steyer's ten largest holdings make up 34% of its $21.4B portfolio in Q3 2021.
  • Thomas Steyer opened 40 new positions and closed 34 in Q3 2021.
  • Thomas Steyer's portfolio value fell 13% quarter-over-quarter to $21.4B.

Based on Farallon Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.